Market opening of imported drugs requested by ustr.

The USTR reported to the U.S. government on April 1 that the non-tariff trade barrier of Korea in pharmaceutical import still stood too high, describing that the imported drugs were significantly discriminated from domestic products.

It was reported that on March 7 the representative of the USTR visited to the Minister of MOHW and strongly requested to the Minister for impo...